Terms: = Thyroid cancer AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16 AND Treatment
11 results:
1. Blood leukocytes as a non-invasive diagnostic tool for thyroid nodules: a prospective cohort study.
Wang F; Zhao D; Xu WY; Liu Y; Sun H; Lu S; Ji Y; Jiang J; Chen Y; He Q; Gong C; Liu R; Su Z; Dong Y; Yan Z; Liu L
BMC Med; 2024 Apr; 22(1):147. PubMed ID: 38561764
[TBL] [Abstract] [Full Text] [Related]
2. Related factor analysis for predicting large-volume central cervical lymph node metastasis in papillary thyroid carcinoma.
Tan L; Ji J; Sharen G; Liu Y; Lv K
Front Endocrinol (Lausanne); 2022; 13():935559. PubMed ID: 36046785
[TBL] [Abstract] [Full Text] [Related]
3. Correlation analysis of I-131 SPECT/CT uptake parameters with the success ablation treatment of thyroid remnant in patients with low-intermediate-risk differentiated thyroid cancer.
Zhang Q; Xu W
Nucl Med Commun; 2022 Oct; 43(10):1051-1057. PubMed ID: 35972341
[TBL] [Abstract] [Full Text] [Related]
4. Single-Cell Transcriptome Analysis Reveals Inter-Tumor Heterogeneity in Bilateral Papillary thyroid Carcinoma.
Wang T; Shi J; Li L; Zhou X; Zhang H; Zhang X; Wang Y; Liu L; Sheng L
Front Immunol; 2022; 13():840811. PubMed ID: 35515000
[TBL] [Abstract] [Full Text] [Related]
5. Metabolic and functional imaging employment in the differentiation of brown tumors from bone metastases in a case of primary papillary thyroid cancer and parathyroid adenoma: case report.
Al-Rasheed U; Barakat F; Al-Ibraheem A
J Egypt Natl Canc Inst; 2021 Oct; 33(1):30. PubMed ID: 34657985
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy of fulvestrant in treating postmenopausal patients with estrogen receptor-positive metastatic breast cancer and prognostic analysis.
Li T; Jiao L
J BUON; 2021; 26(1):189-195. PubMed ID: 33721451
[TBL] [Abstract] [Full Text] [Related]
7. Estimation of Future cancer Burden Among Rescue and Recovery Workers Exposed to the World Trade Center Disaster.
Singh A; Zeig-Owens R; Moir W; Hall CB; Schwartz T; Vossbrinck M; Jaber N; Webber MP; Kelly KJ; Ortiz V; Koffler E; Prezant DJ
JAMA Oncol; 2018 Jun; 4(6):828-831. PubMed ID: 29710126
[TBL] [Abstract] [Full Text] [Related]
8. Systematic differences between ultrasound and pathological evaluation of thyroid nodules: a method comparison study.
Chew CR; Lam T; Chan STF; Chin-Lenn L
ANZ J Surg; 2018 May; 88(5):464-467. PubMed ID: 28608502
[TBL] [Abstract] [Full Text] [Related]
9. Utility of I-124 PET/CT in identifying radioiodine avid lesions in differentiated thyroid cancer: a systematic review and meta-analysis.
Santhanam P; Taieb D; Solnes L; Marashdeh W; Ladenson PW
Clin Endocrinol (Oxf); 2017 May; 86(5):645-651. PubMed ID: 28160320
[TBL] [Abstract] [Full Text] [Related]
10. The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment.
Sohn SY; Choi JH; Kim NK; Joung JY; Cho YY; Park SM; Kim TH; Jin SM; Bae JC; Lee SY; Chung JH; Kim SW
Thyroid; 2014 May; 24(5):872-7. PubMed ID: 24295076
[TBL] [Abstract] [Full Text] [Related]
11. Association of thyroid carcinoma with malignant lymphoma.
Bakri KM; Shimaoka K; Gajera R; Getaz EP; Friedman M; Walsh D; Tsukada Y
Jpn J Clin Oncol; 1983 Dec; 13(4):645-55. PubMed ID: 6645082
[TBL] [Abstract] [Full Text] [Related]
